Tesamorelin, also known as TH9507, is a synthetic stabilized analog of human growth hormone?releasing hormone (GHRH?1?44) with N?terminal trans?3?hexenoyl modification. This special modification protects the peptide from DPP?IV enzymatic degradation, greatly improving its metabolic stability and half?life while maintaining high binding affinity to GHRH receptors.

As a well?studied GHRH analog, Tesamorelin can activate pituitary GHRH receptors to trigger endogenous growth hormone GH and IGF?1 secretion, widely applied in scientific research covering visceral fat metabolism, lipodystrophy study, hormone axis research, aging?related mechanism and lipid profile investigation.

Our Tesamorelin peptide is synthesized under strict quality control. Each batch is tested by HPLC and MS verification, complete COA document is available upon request. The lyophilized powder is packed in inert?gas sealed vials to minimize moisture exposure during transportation and storage.

Tesamorelin is a chemically stabilized analog of human growth?hormone?releasing hormone, modified at the N?terminal position to resist rapid enzymatic degradation within biological environments. This structural modification slows down peptide cleavage, delivering extended exposure duration for pre?clinical laboratory investigations focused on endocrine signaling networks.

Production adopts solid?phase synthetic technology with step?wise amino?acid coupling, followed by preparative chromatography to eliminate deletion variants and oxidative by?products. Each batch goes through mass spectral identification alongside HPLC purity profiling, confirming molecular integrity and low impurity background, which is critical for reproducible endocrinology experiments. This research peptide is frequently applied in studies exploring GH release mechanism, adipose tissue redistribution models, and neuroendocrine pathway analysis.

Lyophilized powder maintains stability under frozen dark dry conditions. Reconstitution should be performed under sterile lab conditions. Since the molecule remains susceptible to proteolytic breakdown in liquid state, repeated freeze?thaw operations must be strictly avoided. Reconstituted aliquots are recommended for short?term cold storage and immediate experimental use.